Drug Trial Radar · NCT02984384
PREVENTion of Clot in Orthopaedic Trauma
Last checked: Nov 19, 2026Latest source record: May 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,424
Actual
Start
Apr 24, 2017
Primary completion
Feb 18, 2022
Study completion Feb 18, 2022
Sponsor
- Lead sponsor
- Major Extremity Trauma Research ConsortiumAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Patient-Centered Outcomes Research Institute
- First posted
- Dec 6, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.
Conditions
- Blood Clot
- Trauma
Interventions
Acetylsalicylic acidDrug
The Aspirin intervention will be 81 mg enteral (by mouth, feeding tube or rectal) twice a day with no variation in dosing allowed.
Low Molecular Weight Heparin (LMWH)Drug
The LMWH intervention will be 30 mg enoxaparin subcutaneous (under the skin) twice a day with variations in dosing allowed, per the standard of care at sites, as needed for patients who are very obese or exhibit renal dysfunction.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With All-cause MortalityTime frame: 90 days
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
University of Arizona
Tucson, Arizona
University of Miami Ryder Trauma Center
Miami, Florida
Methodist Hospital
Indianapolis, Indiana
University of Maryland R Adams Cowley Shock Trauma Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Carolinas Medical Center
Charlotte, North Carolina
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina
MetroHealth Medical Center
Cleveland, Ohio
Allegheny General Hospital
Pittsburgh, Pennsylvania
Rhode Island Hospital, Brown University
Providence, Rhode Island
University of Tennessee, RegionOne Medical Center
Memphis, Tennessee
Vanderbilt Medical Center
Nashville, Tennessee
University of Texas Health Science Center at Houston
Houston, Texas
San Antonio Military Medical Center
San Antonio, Texas
Inova Fairfax Hospital
Falls Church, Virginia
Harborview Medical Center
Seattle, Washington
University of Wisconsin
Madison, Wisconsin
University of Calgary, Foothills Medical Centre
Calgary, Alberta, Canada
McMaster University, Hamilton General Hospital
Hamilton, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.